J.&J. Fined $1.2 Billion in Risperdal Drug Case

A judge in Arkansas ordered Johnson & Johnson and a subsidiary to pay more than $1.2 billion in fines on Wednesday, a day after a jury found that the companies had minimized or concealed the dangers associated with an antipsychotic drug. Risperdal.

Read More here.

 

About these ads

5 thoughts on “J.&J. Fined $1.2 Billion in Risperdal Drug Case

  1. That is very concerning since I take Risperdal. Until this post I was completely oblivious to this.

    Thanks for sharing it.
    Kind Regards

    Kevin

  2. Thank you for reporting this breaking news,the atypical antipsychotic drug promoters are ‘reaping the whirlwind’.My case was with Eli Lilly Zyprexa same saga.
    Four years of off-label Zyprexa use gave me life-long diabetes.-Daniel Haszard
    FMI zyprexa-victims.(dot)com

    • I’m so sorry to hear that, Daniel. I’m currently having a bit of a battle with my Drs over Abilify causing weight gain (they claim it isn’t – just began a post on the topic). I think medicine will one day look back and see what a bad idea these drugs were. Until then, what’s a Bipolar to do? Hope you’re doing well.

  3. Hooray! It’s time pharm companies were made accountable. While the lawsuits may increase the cost of drugs, it feels like a step in weaning the medical profession off the automatic use of meds as “the answer” as well as the drug companies’ stranglehold on medical care.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s